Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection (NOTUBE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00841750|
Recruitment Status : Unknown
Verified July 2011 by Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle.
Recruitment status was: Recruiting
First Posted : February 11, 2009
Last Update Posted : July 20, 2011
|Condition or disease||Intervention/treatment||Phase|
|Lung Diseases, Interstitial Pulmonary Nodule, Solitary||Procedure: Do not leave a chest tube in the pleural cavity. Procedure: Do leave a chest tube in the pleural cavity.||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||The NoTube Study: Evaluation of the Necessity of a Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection.|
|Study Start Date :||July 2008|
|Estimated Primary Completion Date :||June 2012|
|Estimated Study Completion Date :||June 2012|
Experimental: No chest tube
No chest tube left in the pleural cavity at the end of a VATS pulmonary wedge resection.
Procedure: Do not leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, an air leak proof will take place and if no air leak is noted, the surgical incisions for thoracoscopy ports will be closed without leaving a chest tube inserted in the pleural cavity of the patient.
Active Comparator: Chest tube
Chest tube left in the pleural cavity at the end of a VATS pulmonary wedge resection.
Procedure: Do leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, a chest tube will be inserted in the pleural cavity of the patient through the inferior surgical incision for thoracoscopy port; the rest of the incisions will be closed.
- Pneumothorax >10% / Hemothorax [ Time Frame: 1 hour and 1-5 days postoperatively ]
- Pain (Visual analogue scale) [ Time Frame: At days 1-5 of hospitalization and at 1 month ]
- Surgical procedure duration [ Time Frame: At the end of surgery ]
- Hospital stay [ Time Frame: At patient discharge ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00841750
|Fundacion Santa Fe de Bogota||Recruiting|
|Bogota, Bogota D.C., Colombia|
|Contact: Luis G Garcia-Herreros, MD (57)1 2152300 ext 1613 firstname.lastname@example.org|
|Principal Investigator: Luis G Garcia-Herreros, MD|
|Clinica Chicamocha||Not yet recruiting|
|Bucaramanga, Santander, Colombia|
|Contact: Carlos E Garavito, MD email@example.com|
|Contact: Luis F Tapias-Vargas 76382822 firstname.lastname@example.org|
|Principal Investigator: Carlos E Garavito, MD|
|Principal Investigator: Luis F Tapias-Vargas|
|Principal Investigator: Laura I Valencia, MD|
|Fundacion Oftalmológica de Santander Clinica Carlos Ardila Lulle||Recruiting|
|Floridablanca, Santander, Colombia|
|Contact: Leonidas Tapias, MD 76384160 ext 1717 email@example.com|
|Contact: Leonidas Tapias-Vargas, MD 76382822 firstname.lastname@example.org|
|Principal Investigator: Leonidas Tapias, MD|
|Principal Investigator: Leonidas Tapias-Vargas, MD|
|Principal Investigator:||Leonidas Tapias, MD||Fundacion Oftalmológica de Santander Clinica Carlos Ardila Lulle|
|Principal Investigator:||Luis C Orozco-Vargas, MD||Universidad Industrial de Santander|
|Study Chair:||Luis F Tapias-Vargas||Universidad Industrial de Santander|